Royalty Payments in Transfer Pricing: Arm's Length Rates

Royalty payments are one of the most scrutinized areas in transfer pricing, and UAE businesses now feel that pressure directly. When one group company pays another for the right to use a brand, patent, or software, the price is not a free choice. Under UAE Corporate Tax, that payment must reflect an arm's length royalty rate: the amount independent parties would have agreed. Get it wrong, or fail to document it, and the deduction is an easy target on audit.

This guide walks you through exactly how to set and defend a royalty rate. You will learn what counts as a royalty, why these payments carry high transfer pricing risk, how the UAE Corporate Tax framework applies, and how the arm's length principle, DEMPE analysis, and the benefit test fit together. We also cover the comparability factors that drive a defensible rate, the transfer pricing methods you can use, worked examples, common mistakes, and practical recommendations you can act on before your next filing.

Key takeaways up front:

• Related-party royalties must be priced at arm's length under the UAE Corporate Tax Law, and the burden of proof sits with the taxpayer.
• DEMPE decides who earns the royalty, not the entity that merely holds legal title.
• A benefit test must show measurable, quantifiable value from using the intangible.
• Benchmarking, comparability analysis, and contemporaneous documentation are what make a royalty rate defensible.

What Is a Royalty in Transfer Pricing?

A royalty is a fee one company pays another for the right to use intangible property without owning it. That intangible could be a patent, a trademark, a brand, technical know-how, software, or a contractual right. The owner licenses the right to use; the user pays a recurring fee, usually calculated as a percentage of sales, a fixed amount per unit, or a share of operating profit.

The critical distinction is between licensing and transfer. Licensing grants a right to use while ownership stays put, and it generates a recurring royalty. A transfer is a sale of ownership, where a one-time valuation drives the price rather than an ongoing fee. Transfer pricing rules treat these very differently, so classifying the arrangement correctly is the first step.

When the licensor and licensee are unrelated, the market sets the rate. When they are related parties inside the same group, there is no independent negotiation, so tax authorities require the royalty to be benchmarked to an arm's length rate. That single requirement is the foundation of everything that follows.

The UAE aligns its definition of an intangible with the OECD approach. An intangible is something that is not a physical or financial asset, can be owned or controlled for commercial use, and would be compensated between independent parties on its use or transfer. The authoritative reference point is the OECD Transfer Pricing Guidelines for Multinational Enterprises and Tax Administrations, which underpin how the UAE interprets intangible transactions.

Why Royalties Are High-Risk in Transfer Pricing

Royalties attract more disputes than almost any other intercompany charge. There are clear reasons why, and understanding them helps you build a stronger position before an auditor ever asks.

First, royalties are easy to inflate or understate. A percentage point difference on a large revenue base moves significant profit between jurisdictions, so tax authorities watch royalty flows closely. This is precisely the profit-shifting concern the OECD addressed through its work on base erosion and profit shifting, where deductible payments like interest and royalties feature prominently.

Second, intangibles are hard to value. Unlike a physical product, a brand or a patent has no obvious market price, and comparable licences are not always available. That uncertainty invites challenge.

Third, royalties often flow to low-substance entities. A group may place its intellectual property in a holding company that does little more than hold legal title. Authorities increasingly ask whether that entity actually earns the return it receives, or whether the reward belongs to the operating companies that build and protect the value.

Fourth, documentation is frequently weak. Many groups have a licence agreement and nothing else. As we explain below, an agreement alone does not prove a royalty is arm's length or that the payer genuinely benefits. Weak documentation is the single most common reason royalty deductions get challenged.

If you are trying to reduce this risk, the answer is not to avoid royalties. It is to price them correctly, align them with substance, and document them thoroughly. That is where structured support from SBC's transfer pricing team makes a practical difference.

The UAE Corporate Tax Framework for Royalties

The UAE introduced Corporate Tax through Federal Decree-Law No. 47 of 2022, which applies to financial years beginning on or after 1 June 2023. You can review the government's overview and the full law on the Ministry of Finance Corporate Tax page, and the consolidated legislation is published as the Federal Decree-Law No. 47 of 2022 and its amendments. The Federal Tax Authority Corporate Tax portal is the operational home for registration, filing, and guidance.

For royalties, three points matter most.

Arm's length pricing is mandatory

The Corporate Tax Law requires all related-party transactions, including royalty payments, to be priced at arm's length. This is not optional and applies regardless of whether the payer is profitable. The standard rate under the regime is 9% on taxable income above the threshold, so a mispriced royalty directly affects the tax base of both the payer and the recipient.

Free zone royalty income needs care

Royalty income earned by a Qualifying Free Zone Person is generally taxed at 9% unless it meets the narrow definition of Qualifying Intellectual Property income and passes the nexus approach. Free zone businesses should not assume royalty income automatically enjoys the 0% rate. The conditions are strict, and related-party royalties must still be priced at arm's length either way. For a full picture of eligibility, review your position with SBC's Corporate Tax advisory.

Withholding tax and cross-border flows

Cross-border royalty payments can raise withholding tax and treaty questions. The UAE currently applies a 0% withholding tax rate on certain UAE-sourced income paid to non-residents, but the treatment of outbound royalties from other jurisdictions depends on local rules and treaty relief. Groups routing royalties through UAE entities should also watch for permanent establishment and place-of-effective-management exposure where substance is thin. These issues sit at the intersection of transfer pricing and international tax, and they need to be managed together.

The Arm's Length Principle Applied to Royalties

The arm's length principle asks a simple question with complex answers: what would independent parties have agreed for this same right, under the same conditions? For royalties, that means comparing the intercompany licence against real or hypothetical third-party licences and adjusting for the differences.

The principle is the international consensus on pricing cross-border transactions between associated enterprises, and it is the backbone of the OECD framework the UAE follows. The detailed guidance on aligning transfer pricing outcomes with value creation comes from OECD BEPS Actions 8 to 10, which cover intangibles and the arm's length treatment of hard-to-value assets.

Applying the principle to a royalty involves three connected steps: identify who should earn the return (DEMPE), confirm the payer genuinely benefits (the benefit test), and benchmark the rate itself (comparability and method selection). Each step is essential, and skipping any one of them leaves a gap an auditor can exploit.

DEMPE: Who Actually Earns the Royalty?

DEMPE stands for Development, Enhancement, Maintenance, Protection, and Exploitation. It is the OECD framework that determines which entities are entitled to the return from an intangible. The core idea is straightforward: the reward should follow the entities that perform these functions and control the associated risks, not simply the entity that holds legal title.

Legal ownership is only the starting point. If a group parks its brand in a holding company that has no people, no decision-making, and no risk control, that company earns only a routine return for holding the asset. The residual profit belongs to the operating entities that develop the technology, run the marketing, defend the trademark, and generate the sales.

In practice, a DEMPE analysis maps each function to the entity that actually performs it:

• Development: who creates the intangible, funds the research, and makes the key decisions?
• Enhancement: who improves it over time through upgrades, extensions, or added features?
• Maintenance: who keeps it current, functional, and commercially relevant?
• Protection: who registers, enforces, and defends the intellectual property rights?
• Exploitation: who commercializes it and turns it into revenue?

The entity that only funds or legally owns the intellectual property, without controlling the risks, is not entitled to the residual reward. This functional matrix, not the licence agreement, is what determines the split on audit. Building it early, and keeping it consistent with how the business actually operates, is one of the most valuable things you can do to protect a royalty deduction.

The Benefit Test: Proving Real Value

Benchmarking a rate is not enough on its own. The payer must also show that it actually benefits from using the intangible. This is the benefit test, and it is where many royalty positions fall apart.

The benefit test requires clear, quantifiable evidence of the economic value the payer derives from the intangible. Merely holding a licence agreement does not satisfy it. You need to demonstrate a measurable link between the intangible and the payer's revenue, cost savings, or market position.

A strong benefit-test position typically shows three things:

1. The intangible delivers real, measurable value (higher sales, premium pricing, lower costs, or faster market access).
2. The intangible is genuinely useful and not readily available from a low-cost alternative.
3. The payer could not easily have developed the intangible internally.

Supporting evidence should include a functional analysis, a DEMPE matrix, an intellectual property register, financial analyses linking the intangible to performance, the underlying licence agreements, board approvals, and the benchmarking study itself. The agreement is one piece of the puzzle, not the whole picture. As we explain in our note on why intercompany agreements matter for UAE transfer pricing, the contract, the actual conduct, and the transfer pricing analysis all need to tell the same story.

Comparability Factors That Drive a Defensible Rate

An arm's length royalty rate is not a single number pulled from a table. It emerges from a careful comparability analysis. Eight factors consistently shape the rate across different types of arrangement:

• Industry: royalty norms differ sharply between pharmaceuticals, consumer goods, and software.
• Type of agreement: exclusive licences command more than non-exclusive ones.
• Royalty base: is the rate applied to net sales, units sold, or operating profit?
• Exclusivity: an exclusive right to a territory or product is worth more.
• Geographic scope: a global licence differs from a single-market one.
• Stage of development: an unproven intangible carries different value from an established one.
• Useful life: how long will the intangible generate value?
• Expected future benefits: what economic upside does the licence unlock?

Each factor needs to be documented and reflected in your comparable search. Adjustments for material differences, such as exclusivity or geography, are what turn a rough market range into a defensible arm's length rate.

Transfer Pricing Methods for Royalties

Three methods dominate royalty benchmarking. The right choice depends on the facts of the arrangement and the data available.

Comparable Uncontrolled Price (CUP)

The CUP method compares the intercompany royalty directly against comparable third-party licence rates. It is the most direct method and the preferred one where reliable comparables exist. Analysts often draw on specialist databases of licence agreements, adjusting for differences in exclusivity, geography, and contractual terms. CUP works best when a genuinely similar third-party licence can be identified.

Profit Split Method (PSM)

The profit split method fits where both parties make unique and valuable contributions to the intangible, so neither can be treated as a simple routine service provider. PSM allocates the combined profit between the parties based on their relative contributions, often guided by the DEMPE analysis. It suits complex, integrated arrangements such as jointly developed technology.

Transactional Net Margin Method (TNMM)

TNMM examines the net profit margin earned relative to an appropriate base, and it suits entity-level analysis where transaction-level comparables are scarce. It is frequently used as a corroborating method or where the licensee is a routine distributor or manufacturer whose overall profitability can be tested against comparables.

The method you select should be the most reliable one given the facts, and your documentation should explain why you chose it and rejected the alternatives.

Method selection at a glance

Practical Business Implications for UAE Groups

For UAE businesses, royalty transfer pricing is no longer a theoretical concern. Documentation obligations under the Corporate Tax regime mean that groups meeting the relevant thresholds must maintain a Local File and Master File aligned to OECD standards, and disclose related-party transactions. The documentation framework follows OECD Action 13 on country-by-country reporting and transfer pricing documentation, which the UAE has adopted in substance.

There are several concrete implications:

• Your royalty must be counted in your related-party disclosures. Under-reporting or misclassifying it creates immediate exposure.
• The gross value of related-party transactions matters for testing whether documentation thresholds are met, so aggregate your royalty flows carefully.
• Free zone entities must protect their status. A mispriced royalty to or from a mainland sister company can undermine a Qualifying Free Zone Person position.
• Consistency is everything. Your licence agreement, your actual conduct, your financial statements, and your transfer pricing analysis must all agree.

Where a royalty position is challenged, the ability to respond quickly with contemporaneous, well-organized evidence often determines the outcome. That is why audit readiness should be built in from the start, not assembled under deadline pressure. If a dispute does arise, structured support through SBC's audit and dispute resolution practice can help you defend the position.

Worked Examples

Example 1: Trademark royalty to a low-substance owner

A UAE operating company pays a 5% royalty on net sales to a group holding company for the use of a global brand. The holding company has no employees and makes no marketing decisions. On a DEMPE analysis, the UAE operating company performs the enhancement, maintenance, and exploitation functions and controls the related risks, while the holding company only holds legal title.

The likely outcome: the holding company is entitled to a routine return for holding the asset, and most of the residual reward belongs to the operating company. A 5% outbound royalty is difficult to defend. The rate should be reduced, or the substance and functions realigned to match the payment. Documenting the DEMPE split and benchmarking the residual return is essential here.

Example 2: Technical know-how royalty for a manufacturer

A UAE manufacturer licenses proprietary process technology from its parent and pays a 3% royalty on production. The parent developed and owns the technology, funds ongoing R&D, and controls the associated risks. The UAE manufacturer uses the technology to produce goods it could not otherwise make.

The likely outcome: the royalty is defensible provided the rate is benchmarked (CUP against comparable technology licences, corroborated by TNMM on the manufacturer's routine margin), the benefit test is satisfied with evidence linking the technology to production capability and cost savings, and the DEMPE functions genuinely sit with the parent. Continued losses at the manufacturer do not, by themselves, justify denying the deduction, provided the arrangement reflects commercial reality.

Common Mistakes to Avoid

Even well-run groups make recurring errors on royalties. Watch for these:

• Relying on the licence agreement alone. A contract does not prove arm's length pricing or benefit. You need benchmarking, DEMPE, and benefit-test evidence.
• Ignoring DEMPE. Paying a full royalty to a legal owner with no substance is the classic trigger for adjustment.
• Skipping the benefit test. If you cannot show measurable value, the deduction is vulnerable.
• Using a stale or generic rate. A rate copied from another group, another year, or another market is not defensible.
• Inconsistent documentation. When the agreement, the conduct, and the financials disagree, the auditor follows the weakest link.
• Assuming a nil royalty is safe. Setting a royalty to zero to avoid the issue is also a transfer pricing position, and it must be justified. Authorities cannot simply set a royalty to nil, but neither can taxpayers assume nil is automatically acceptable.
• Overlooking free zone conditions. Assuming royalty income qualifies for 0% without testing the Qualifying Intellectual Property and nexus conditions.

Practical Recommendations

Here is a practical checklist to strengthen your royalty position before your next Corporate Tax filing:

1. Map your intangibles. Build an IP register that lists every intangible, its legal owner, and its economic value drivers.
2. Run a DEMPE analysis. Document which entity performs and controls each DEMPE function, and check it against how the business actually operates.
3. Satisfy the benefit test. Gather quantifiable evidence linking each intangible to revenue, margin, or cost outcomes for the payer.
4. Benchmark the rate. Select the most reliable method, run a comparability analysis, and document your comparable selection and rejection rationale.
5. Align the paperwork. Make sure the intercompany agreement reflects the actual conduct and the transfer pricing analysis.
6. Prepare your files. Ensure your royalty is captured in disclosures and supported in your Local File and Master File.
7. Review annually. Refresh benchmarking and revisit DEMPE as the business, the market, and the intangible evolve.

If you want a structured review of your royalty arrangements before you file, you can contact SBC to arrange a confidential conversation. You can also read our detailed insight on royalty payments and arm's length rates for further technical depth.

Frequently asked questions

How is an arm's length royalty rate determined?

An arm's length royalty rate is set by benchmarking the intercompany licence against comparable third-party arrangements, most often using the CUP, profit split, or TNMM method. The analysis weighs eight comparability factors, including exclusivity, geographic scope, the royalty base, useful life, and the stage of development of the intangible. The rate must be supported by a functional analysis and contemporaneous documentation.

Are related-party royalties always taxable in the UAE?

Related-party royalties must always be priced at arm's length under UAE Corporate Tax, regardless of the payer's profitability. Royalty income is generally taxed at 9%. A Qualifying Free Zone Person may access the 0% rate only where the income meets the narrow definition of Qualifying Intellectual Property income and passes the nexus approach, so free zone businesses should test their position carefully.

What is the benefit test for royalty payments?

The benefit test requires the payer to show clear, quantifiable economic value from using the intangible. Simply holding a licence agreement is not enough. The taxpayer should demonstrate that the intangible is genuinely useful, was not available from a low-cost alternative, and could not easily have been developed internally, supported by financial evidence linking it to performance.

Does DEMPE decide who earns a royalty?

Yes. Under the DEMPE framework, the return from an intangible follows the entities that develop, enhance, maintain, protect, and exploit it and control the related risks, not simply the entity that holds legal title. A related party that only funds or legally owns the intellectual property, without substance, earns a routine return, while the residual reward goes to the DEMPE performers.

Can a tax authority set a royalty to nil?

Tax authorities cannot simply set a royalty to nil because manufacturing is outsourced or the payer is loss-making. However, the taxpayer still carries the burden of proving DEMPE alignment, a genuine benefit, and an arm's length rate. A nil royalty is itself a transfer pricing position that must be justified with evidence.

What documentation do I need to support a royalty?

You should maintain an intellectual property register, a functional analysis, a DEMPE matrix, benefit-test evidence, the benchmarking study, the intercompany agreement, board approvals, and financial analyses linking the intangible to performance. This evidence should be captured in your Local File and Master File and be consistent with your related-party disclosures.

Conclusion

Royalty payments sit at the crossroads of value, tax, and risk, which is exactly why they draw so much attention under UAE Corporate Tax. The path to a defensible position is clear: classify the arrangement correctly, use DEMPE to identify who truly earns the return, prove real benefit to the payer, and benchmark the rate with the most reliable method and solid comparability analysis. Wrap it all in consistent, contemporaneous documentation, and align the agreement with actual conduct.

The next step is practical. Review your current royalty arrangements against the checklist above, identify where your documentation is thin, and close those gaps before your filing deadline rather than after an audit query. A well-prepared royalty position protects your deduction, supports your free zone status where relevant, and gives you confidence that your numbers will hold up under scrutiny. Which part of your royalty documentation would survive an FTA review today?

15/9/25 UAE QFZP Framework

Page Title: UAE QFZP Qualifying Activities Under Ministerial Decision No. 229 of 2025
Meta Title: UAE QFZP Rules: Ministerial Decision 229 of 2025 Explained
Meta Description: Understand UAE QFZP qualifying activities under Ministerial Decision No. 229 of 2025, its retrospective effect, the 0% and 9% rates, substance, and transfer pricing duties.
Primary Keywords: QFZP qualifying activities, Ministerial Decision 229 of 2025, Qualifying Free Zone Person UAE
Secondary Keywords: free zone 0% corporate tax, qualifying income, excluded activities, Article 18 QFZP conditions, UAE Corporate Tax free zone, Federal Decree-Law No. 47 of 2022
Slug: uae-qfzp-qualifying-activities-ministerial-decision-229-2025